Concentrix: EPS is estimated at 0.06 $

Investing.com – Concentrate (NASDAQ: ) reported a quarterly EPS of $2.87, $0.06 lower than the analyst estimate of $2.93.

The costs for the purchase of fourteen years of faith are priced at 2.39B$, the cut-through estimates can be purchased at 2.38B$.

Forecasts

I celebrate Q2 2024 with a Concentrix with an EPS of $2.90-$3.16. Analysts hate my opinion with a revenue of $3.48.

The Umsatz estimates Concentrix in four months quarter 2024 at $2.42B-$2.47B. Experts hate im Schnitt with 2.47B$gericht.

Im Geschäftsjahr 2024 rechnet Concentrix with an EPS of 11.05$-11.31$. Analysts hate my opinion with 11.71$gericht.

The Umsatz schätzt Concentrix in the Geschäftsjahr 2024 at 9.59B$-9.64B$. Experts hate im Schnitt with 9.63B$gericht.

The Concentrix Action has put the official Trading at the Closing Level of 63.62$. In the last 3 months the Performance was plus 0.54%, in the last 12 months at minus -10.72%.

Concentrix achieved in the last 90 days 0 positive EPS revisions and 3 negative EPS revisions. The early reactions of the Concentrix action courses to the advance payment of the business amounts could be a fact here.

InvestingPro uses Concentrix’s financial financing on the Grundlage that uses financial knowledge as “gut”.

Information about the concentrix that the balance knowledge finds here.